Okada Y, Kumagai Y, Okura I, Otsuki M, et al. Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial. Lancet Infect Dis 2024 Oct 23:S1473-3099(24)00565.
PMID: 39461355